These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11445748)

  • 1. Bactericidal/permeability-increasing protein--lessons learned from the phase III, randomized, clinical trial of rBPI21 for adjunctive treatment of children with severe meningococcemia.
    Giroir BP; Scannon PJ; Levin M
    Crit Care Med; 2001 Jul; 29(7 Suppl):S130-5. PubMed ID: 11445748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.
    Levin M; Quint PA; Goldstein B; Barton P; Bradley JS; Shemie SD; Yeh T; Kim SS; Cafaro DP; Scannon PJ; Giroir BP
    Lancet; 2000 Sep; 356(9234):961-7. PubMed ID: 11041396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis.
    Giroir BP; Quint PA; Barton P; Kirsch EA; Kitchen L; Goldstein B; Nelson BJ; Wedel NJ; Carroll SF; Scannon PJ
    Lancet; 1997 Nov; 350(9089):1439-43. PubMed ID: 9371168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal/permeability-increasing protein (rBPI21) in patients with hemorrhage due to trauma: results of a multicenter phase II clinical trial. rBPI21 Acute Hemorrhagic Trauma Study Group.
    Demetriades D; Smith JS; Jacobson LE; Moncure M; Minei J; Nelson BJ; Scannon PJ
    J Trauma; 1999 Apr; 46(4):667-76; discussion 676-7. PubMed ID: 10217232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of bactericidal/permeability-increasing protein (rBPI21) in baboon sepsis is related to its antibacterial, not antiendotoxin, properties.
    Schlag G; Redl H; Davies J; Scannon P
    Ann Surg; 1999 Feb; 229(2):262-71. PubMed ID: 10024109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meningococcemia as a model for testing the hypothesis of antisepsis therapies.
    Giroir BP
    Crit Care Med; 2000 Sep; 28(9 Suppl):S57-9. PubMed ID: 11007199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant bactericidal/permeability-increasing protein (rBPI21) for treatment of parvovirus enteritis: a randomized, double-blinded, placebo-controlled trial.
    Otto CM; Jackson CB; Rogell EJ; Prior RB; Ammons WS
    J Vet Intern Med; 2001; 15(4):355-60. PubMed ID: 11467593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of meningococcal infections in children in mid-southern part of Turkey.
    Alhan E; Bozdemir N; Yüksel B; Onenli N; Kocabaş E; Aksaray N
    Eur J Epidemiol; 1995 Aug; 11(4):393-6. PubMed ID: 8549705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil response to Neisseria meningitidis: inhibition of adhesion molecule expression and phagocytosis by recombinant bactericidal/permeability-increasing protein (rBPI21).
    Heyderman RS; Ison CA; Peakman M; Levin M; Klein NJ
    J Infect Dis; 1999 May; 179(5):1288-92. PubMed ID: 10191239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuprex XOMA Corp.
    Mackin WM
    IDrugs; 1998 Oct; 1(6):715-23. PubMed ID: 18465627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant N-terminal fragment of bactericidal/permeability increasing protein (rBPI21) prevents shock-induced microcirculatory alterations in the liver.
    Bauer C; Riemer-Paxian I; Larsen R; Marzi I
    Crit Care Med; 1997 Aug; 25(8):1283-8. PubMed ID: 9267939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of recombinant bactericidal/permeability-increasing protein on endotoxin translocation and lipopolysaccharide-binding protein/CD14 expression in rats after thermal injury.
    Fang WH; Yao YM; Shi ZG; Yu Y; Wu Y; Lu LR; Sheng ZY
    Crit Care Med; 2001 Jul; 29(7):1452-9. PubMed ID: 11445707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH; Ammons WS; Bauer RJ; Dedrick R; Nadell R; Williams RE; Liu PS
    J Endotoxin Res; 2004; 10(2):97-106. PubMed ID: 15120000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meningococcal disease as a model to evaluate novel anti-sepsis strategies.
    Cohen J
    Crit Care Med; 2000 Sep; 28(9 Suppl):S64-7. PubMed ID: 11007201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antibiotics and outcome in meningococcemia.
    Radetsky M
    Arch Intern Med; 2000 Jul; 160(14):2220-3. PubMed ID: 10904473
    [No Abstract]   [Full Text] [Related]  

  • 16. Protective effects of an N-terminal fragment of bactericidal/permeability-increasing protein in rodent models of gram-negative sepsis: role of bactericidal properties.
    Ammons WS; Kohn FR; Kung AH
    J Infect Dis; 1994 Dec; 170(6):1473-82. PubMed ID: 7995987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein and cefamandole in treatment of rabbit gram-negative sepsis.
    Lin Y; Leach WJ; Ammons WS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):65-9. PubMed ID: 8787881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bactericidal/permeability-increasing protein in host defense and its efficacy in the treatment of bacterial sepsis.
    Levy O; Elsbach P
    Curr Infect Dis Rep; 2007 Oct; 3(5):407-12. PubMed ID: 24395478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of a recombinant modified amino terminal fragment of bactericidal/permeability-increasing protein (rBPI21) in healthy volunteers.
    Bauer RJ; Wedel N; Havrilla N; White M; Cohen A; Carroll SF
    J Clin Pharmacol; 1999 Nov; 39(11):1169-76. PubMed ID: 10579148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bactericidal/permeability-increasing protein (BPI) in antibacterial host defense.
    Elsbach P
    J Leukoc Biol; 1998 Jul; 64(1):14-8. PubMed ID: 9665269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.